Cabometyx® (cabozantinib)
for Renal Cell Carcinoma
Cabometyx (cabozantinib) is an oral tablet taken once daily to treat advanced kidney cancer, sometimes with nivolumab, liver cancer (hepatocellular carcinoma) after sorafenib, differentiated thyroid cancer (DTC) that has spread and progressed after VEGFR-targeted treatment, and pancreatic/extra-pancreatic neuroendocrine tumors (pNET and epNET). It is a kinase inhibitor that blocks tyrosine kinases involved in cancer growth, spread, and tumor maintenance.
